Russell Investments Group
NVCR icon

Russell Investments Group’s NovoCure NVCR Stock Holding History

Russell Investments Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
146,098
-9,101
-6% -$114K ﹤0.01% 1985
2025
Q4 		$2.01M Buy
155,199
+114,209
+279% +$1.47M ﹤0.01% 1857
2025
Q3 		$530K Buy
40,990
+37,539
+1,088% +$502K ﹤0.01% 2453
2025
Q2 		$61.4K Sell
3,451
-3,078
-47% -$53.6K ﹤0.01% 2932
2025
Q1 		$116K Buy
6,529
+5,371
+464% +$122K ﹤0.01% 2722
2024
Q4 		$34.5K Sell
1,158
-2,135
-65% -$45.2K ﹤0.01% 2906
2024
Q3 		$51.5K Sell
3,293
-8,281
-72% -$150K ﹤0.01% 2786
2024
Q2 		$198K Sell
11,574
-118,708
-91% -$2.09M ﹤0.01% 2482
2024
Q1 		$2.04M Buy
130,282
+92,771
+247% +$1.36M ﹤0.01% 1642
2023
Q4 		$576K Sell
37,511
-28,744
-43% -$385K ﹤0.01% 2167
2023
Q3 		$1.08M Sell
66,255
-12,410
-16% -$358K ﹤0.01% 1880
2023
Q2 		$3.24M Sell
78,665
-7,543
-9% -$468K 0.01% 1287
2023
Q1 		$5.13M Buy
86,208
+47,493
+123% +$3.8M 0.01% 1097
2022
Q4 		$2.78M Buy
38,715
+434
+1% +$32.7K 0.01% 1384
2022
Q3 		$2.94M Buy
38,281
+1,519
+4% +$118K 0.01% 1339
2022
Q2 		$2.64M Buy
36,762
+98
+0.3% +$7.38K 0.01% 1436
2022
Q1 		$3.07M Buy
36,664
+613
+2% +$45.2K 0.01% 1412
2021
Q4 		$2.85M Buy
36,051
+524
+1% +$52.6K ﹤0.01% 1612
2021
Q3 		$4.12M Buy
35,527
+726
+2% +$110K 0.01% 1362
2021
Q2 		$7.76M Sell
34,801
-49,018
-58% -$9.54M 0.01% 1071
2021
Q1 		$10.9M Buy
83,819
+11,386
+16% +$1.8M 0.02% 891
2020
Q4 		$12.6M Buy
72,433
+35,378
+95% +$4.84M 0.02% 724
2020
Q3 		$4.07M Sell
37,055
-27,916
-43% -$2.23M 0.01% 1255
2020
Q2 		$3.81M Sell
64,971
-7,147
-10% -$470K 0.01% 1269
2020
Q1 		$4.93M Buy
72,118
+37,113
+106% +$2.93M 0.01% 959
2019
Q4 		$2.98M Sell
35,005
-3,686
-10% -$298K 0.01% 1504
2019
Q3 		$2.85M Buy
38,691
+944
+3% +$75.5K 0.01% 1498
2019
Q2 		$2.3M Sell
37,747
-325
-0.9% -$16.5K ﹤0.01% 1601
2019
Q1 		$1.79M Buy
38,072
+35,917
+1,667% +$1.73M ﹤0.01% 1771
2018
Q4 		$71K Sell
2,155
-7,073
-77% -$259K ﹤0.01% 2762
2018
Q3 		$484K Hold
9,228
– – ﹤0.01% 2405
2018
Q2 		$289K Sell
9,228
-13,810
-60% -$384K ﹤0.01% 2561
2018
Q1 		$502K Sell
23,038
-1,764
-7% -$37.9K ﹤0.01% 2472
2017
Q4 		$508K Hold
24,802
– – ﹤0.01% 2431
2017
Q3 		$492K Buy
24,802
+3,876
+19% +$76.2K ﹤0.01% 2446
2017
Q2 		$362K Buy
+20,926
New +$270K ﹤0.01% 2533
2017
Q1 		– Sell
-10,434
Closed -$80K – 3046
2016
Q4 		$80K Buy
+10,434
New +$83.9K ﹤0.01% 2919

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Russell Investments Group's NVCR Position: Q1 2026 in Review

Russell Investments Group reduced its NovoCure (NVCR) stake by 5.9% in Q1 2026, selling an estimated $114K and leaving 146,098 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Russell Investments Group first reported a position in NVCR in Q4 2016 and has held it in 37 quarters since. The position peaked at $12.6M in Q4 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Russell Investments Group held 146,098 shares of NovoCure worth $1.59M as of Q1 2026.
  • Russell Investments Group sold 9,101 NovoCure shares in Q1 2026, an estimated $114K.
  • NovoCure made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #1985 holding.
  • Russell Investments Group first reported a position in NovoCure in Q4 2016 and has held it in 37 quarters since.
  • Russell Investments Group's NovoCure position peaked at $12.6M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.